Posts by: Magdalena Kegel

Magdalena Kegel

Magdalena is a writer with a passion for bridging the gap between the people performing research, and those who want or need to understand it. She writes about medical science and drug discovery. She holds an MS in Pharmaceutical Bioscience and a PhD — spanning the fields of psychiatry, immunology, and neuropharmacology — from Karolinska Institutet in Sweden.

March 16, 2016March 16, 2016

1st Lymphoma Patient, a Doctor, Being Treated with CAR T-cell Therapy in Phase 2 Study

News

The Wilmot Cancer Institute at the University of Rochester has initiated treatment of the first patient enrolled in a clinical trial of CAR T-cell therapy for lymphoma. The therapy has ... Read more

March 14, 2016March 14, 2016

Lymphoma Study Sees Early Promise in Pathway Targeting Cancerous B-Cells

News

Wistar Institute researchers recently discovered that a protein in the endoplasmic reticulum, called STING, can stimulate the immune system to kill malignant B-cells — the cause of several lymphomas. The ... Read more

March 10, 2016March 10, 2016

Key Precursor Blood Stem Cells for Lymphoma Therapies Identified in Mouse Study

News

Researchers have identified cells in mouse placentas and embryos that are precursors to blood stem cells and can be matured in the lab to produce these cells — suggesting a new way of ... Read more

February 11, 2016February 11, 2016

Follicular Lymphoma Patients Can Safely Use Statins During Rituximab Treatment, Study Reports

News

Although statin use has been poorly associated with rituximab in laboratory experiments, a study investigating the concomitant use of statins and rituximab in follicular lymphoma patients has concluded that statin use is safe and ... Read more

February 3, 2016February 3, 2016

Hodgkin Lymphoma Treatment Using Radiation Linked to Coronary Heart Disease

News

Hodgkin lymphoma (HL) survivors are at a greater risk of developing coronary heart disease, most likely due to their exposure to radiation of the heart during cancer treatment, researchers said in a study published ... Read more

January 29, 2016January 29, 2016

Lymphoma Development Linked in Study to Mutations in Gene Regulating Plasma Cells

News

Two studies, published in the journal Nature Immunology, highlight the crucial role of mutations in the Blimp1 gene in lymphoma development. The work centers on plasma cells, or immune cells that develop ... Read more

January 25, 2016January 25, 2016

Immunotherapy for Lymphomas Related to EBV Entering Clinical Trial in Canada

News

Health Canada recently approved a Phase I clinical trial of adoptive cellular immunotherapy specific to Epstein-Barr virus (EBV) aimed at treating EBV-associated lymphomas. The technique is an adaptation of methods initially ... Read more

January 20, 2016January 20, 2016

ALC Lymphoma’s Origin Traced to the Thymus, Raising Treatment Possibilities

News

Researchers in the U.K. have traced the origins of anaplastic large cell lymphoma (ALCL) to the thymus, raising the possibility that new treatments may be designed to more effectively prevent ALCL relapse. Their study was published in Nature Communications. ALCL is ... Read more

January 15, 2016January 15, 2016

Childhood Cancer Survival Rates Rising with Improved Treatments, Study Reports

News

Results from the Childhood Cancer Survivor Study (CCSS) show that current advances in treatment and follow-up have led to improved survival of childhood cancers, including lymphoma, especially by reducing deaths due to lingering effects of cancer treatment. The ... Read more

January 8, 2016January 8, 2016

Nanovehicle RNA Delivery System to Treat Mantle Cell Lymphoma Patients

News

A study from Tel Aviv University in Israel recently published in the early edition of the journal Proceedings of the National Academy of Sciences USA (PNAS) describes a revolutionary new technique involving a nanovehicle for ... Read more